US Patent Issued to Cedars-Sinai Medical Center on Jan. 13 for "Systems and methods for the assessment of cardiac amyloidosis" (California Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,078, issued on Jan. 13, was assigned to Cedars-Sinai Medical Center (Los Angeles).

"Systems and methods for the assessment of cardiac amyloidosis" was invented by Piotr Slomka (Los Angeles), Sebastien Cadet (Los Angeles), Paul Kavanagh (Santa Monica, Calif.) and Tejas Parekh (San Gabriel, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Assessment of transthyretin amyloid cardiomyopathy (ATTR-CM) can be performed by calculating a cardiac pyrophosphate activity (CPA) measurement from single-photon emission computed tomography (SPECT) images. SPECT images obtained using 99mTechnetium-pyrophosphate as a radiotracer can be analyzed to calculate CPA...